Evidence mapPaperPMID 39717555Full record

ReviewFrontiers in pharmacology2024

Research progress of traditional Chinese medicine regulating intestinal flora in the treatment of hypertension.

Wenjun Chen, Longfei Xiao, Wenlong Guo, Hailin Li, Rong Chen, Zhongyu Duan, Qinghua Chen, Qing Lei

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Potential protective effects ofFrontiers in pharmacology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wenjun ChenCollege of Ethnic Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Longfei XiaoCollege of Ethnic Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Wenlong GuoCollege of Ethnic Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Hailin LiCollege of Ethnic Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Rong ChenCollege of Ethnic Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Zhongyu DuanCollege of Ethnic Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Qinghua ChenCollege of Ethnic Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Qing LeiDepartment of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is a common disease; however, it is more prevalent in older adults, and its prevalence is increasing in younger populations. Numerous studies have revealed that hypertension and the composition and functionality of the intestinal flora are closely correlated. The balance of the intestinal flora, intestinal barrier integrity, and metabolite content of the intestinal flora play significant roles in the occurrence and progression of hypertension. Therefore, we performed a comprehensive review of Traditional Chinese medicine (TCM) for hypertension, focusing on the role of the intestinal flora to understand the mechanism by which TCM regulates hypertension through its effects on the intestinal flora. We analyzed the findings using the terms "traditional Chinese medicine," "hypertension," "high blood pressure," "blood pressure," "intestinal flora," "intestinal barrier function," "intestinal flora metabolites," and other keywords from the China National Knowledge Infrastructure, VIP Chinese Science and Technology, Wanfang Data, PubMed, and ScienceDirect databases. We found that TCM treats hypertension by regulating the balance of the intestinal microbiota, increasing the abundance of beneficial bacteria, reducing the abundance of harmful bacteria, improving intestinal barrier function, increasing compact proteins, reducing intestinal permeability, and regulating the content of intestinal flora metabolites. The use of TCM to treat hypertension by regulating the intestinal flora is a promising therapeutic strategy. However, most studies are limited by small sample sizes and there is a lack of large-scale randomized controlled trials. In the future, multi-center controlled clinical trials are needed to verify the efficacy and safety of TCM, optimize therapeutic protocols, and establish a foundation for the standardized and personalized application of TCM in hypertension management.

Indexed as

hypertensionintestinal barrier functionintestinal floraintestinal flora metabolitestraditional Chinese medicine (TCM)

Identifiers

PMID39717555
PMCPMC11664361

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.